Complications following Breast Augmentation using Injectable Fillers in Kuwait.

Abstract

Objectives: The study aims to evaluate and present clinical outcomes and complications associated with breast augmentation using injectable fillers and autologous fat transfer.

Methods: This is a retrospective case series of patients who presented with complications following breast augmentation via injectable fillers or autologous fat grafting between September 2015 and November 2019 at a private clinic in Kuwait.

Results: Amongst the 10 patients, 8 had complications from injectable fillers; co-polyamide (n=4), hyaluronic acid (n=1), collagen (n=1), unknown materials (n=3) and 2 from autologous fat transfer. Common complications included mastalgia (90%), palpable masses (80%), cyst formation (80%), filler migration (30%), and infection (20%). Imaging revealed multiple cystic lesions, filler deposition, and inflammatory changes, with several cases categorized as Breast Imaging Reporting and Data System-4 (BIRADS-4), which required biopsy. Surgical interventions, including mastectomy and drainage, were required in 40% of cases, while others were managed conservatively with imaging follow-up and/or aspiration.

Conclusion: Injectable fillers for breast augmentation, particularly unregulated substances, are associated with a high risk of serious complications requiring invasive management. This study emphasizes the need for strict regulation, increased public awareness, and reliance on FDA-approved methods such as silicone implants or autologous fat grafting.